HbA1c檢驗的全球市場:趨勢,技術,成長機會(2025年)
市場調查報告書
商品編碼
1664022

HbA1c檢驗的全球市場:趨勢,技術,成長機會(2025年)

The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025

出版日期: | 出版商: Kalorama Information | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

自 1990 年代以來,HbA1c 測試對於監測糖尿病患者的長期血糖控制至關重要,並且補充了診斷性血糖測試。最近的研究強調了 HbA1c 測試在糖尿病篩檢和患者監測中的實用性,尤其是與空腹血糖 (FBG) 測試相結合時。該報告涵蓋了實驗室和臨床點 HbA1c 檢測設備,並提供了全球視角以及特定的區域分析。

HbA1c 檢測產業面臨獨特的挑戰,包括集團採購組織和政府的報銷審批和價格談判。持續的研發投入對於創新和市場成功至關重要。儘管面臨這些挑戰,但 HbA1c 檢測產業仍受益於全球人口老化和新興市場醫療保健支出的增加。

表面化學、奈米技術和分析科學的進步有望實現更方便、更準確、非侵入性的 HbA1c 測量。深度機器學習演算法與糖尿病管理行動應用程式的整合有望減少住院治療並改善患者治療效果,開創醫療保健創新的新時代。

本報告研究了全球 HbA1c 檢測市場,並提供了有關 HbA1c 總市場價值以及檢測應用、技術和市場參與者細分市場的資訊。詳細的公司簡介提供了競爭見解。市場數據反映的是製造商層面的全球市場,基準年為 2024 年。在人口趨勢、技術創新和全球市場擴張的推動下,我們預測了 2024 年至 2029 年的複合年增長率 (CAGR),並提供 2024 年的競爭分析和區域細分。

目錄

第1章 摘要整理

第2章 簡介

  • 概要
    • 診斷
    • 分類
    • 妊娠
    • 其他
    • 風險要素
    • 糖尿病的人口統計
    • 國際統計
    • 美國的盛行率
    • 美國的發生率
    • 美國的死亡人數
    • 美國成本
  • HbA1c

第3章 按HbA1c檢驗,場所

  • 簡介
    • 實驗室中的 HbA1c 檢測
    • 護理點糖化血紅素 (HbA1c) 檢測
  • 地區劃分的 HbA1c 檢測市場

第4章 HbA1c檢驗市場,技術各平台

  • 概要
    • 層析法
    • 高效液相層析法 (HPLC)
    • 硼酸鹽親和力
    • 免疫測定
    • 酶法和微光學法
    • 其他
  • 各技術市場

第5章 與HbA1c檢驗市場概要競爭

  • 全球HbA1c市場全體
  • 各國市場分析
  • 北美
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
  • 南美
  • 其他
  • 競爭分析

第6章 HbA1c檢驗市場課題和趨勢

  • 世界衛生組織基本體外診斷試劑清單
  • 糖白蛋白測試
  • 報告變更
  • PAMA 面臨的挑戰
  • A1c 的種族差異
  • 遠距醫療
  • LDT 更新
  • 醫療保險和 HbA1c 測試
  • IT 和人工智慧
  • 糖尿病與老化社會
  • 老化的影響
  • 醫療效率
  • 糖尿病併發症
  • 監理問題
  • 牙醫診所的 HbA1c 檢測

第7章 HbA1c檢驗市場企業簡介

  • 簡介
  • Abbott
  • A. Menarini Diagnostics, S.r.l.
  • ARKRAY, Inc
  • Beckman Coulter/Danaher
  • Bio-Rad
  • DiaSys Diagnostics Systems GmbH
  • Diazyme Laboratories, Inc
  • EKF Diagnostics Holdings Plc
  • HemoCue/Danaher
  • HUMAN Diagnostics
  • OSANG Healthcare Co, Ltd
  • PTS Diagnostics, Inc
  • QuidelOrtho Corporation
  • Roche Diagnostics Corporation
  • Sebia
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers GmbH
  • Tosoh Bioscience, LLC
  • Trinity Biotech
簡介目錄
Product Code: 25-070KA

Kalorama Information's "The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025" provides a comprehensive analysis of the global HbA1c testing market, highlighting key trends, technological advancements, and growth opportunities. This report delves into the geographical distribution, demographic influences, and critical market issues shaping the industry. It offers a detailed examination of market values, regional dynamics, and competitive landscapes, with insights into leading providers.

Since the 1990s, HbA1c testing has been pivotal in monitoring long-term glycemic control in diabetics, complementing glucose tests for diagnosis. Recent research underscores the HbA1c test's utility in diabetes screening and patient monitoring, especially when combined with fasting blood glucose (FBG) tests. The report covers both lab-based and point-of-care HbA1c test devices, providing a global perspective with specific regional analyses.

The market summary includes total HbA1c market values, segmented by test usage, technology, and market participation. Detailed company profiles offer competitive insights. The report's data is derived from extensive primary and secondary research, including interviews with over 20 industry experts, healthcare providers, and government officials. Additional insights were gathered from company representatives, ensuring a robust and accurate market overview.

Market data reflects the world market at the manufacturers' level, with 2024 as the base year. Compound annual growth rates (CAGRs) are projected for the 2024-2029 period, supported by demographic trends, technological innovations, and global market expansion. Competitive analysis and regional breakdowns for 2024 are also provided.

The HbA1c testing industry faces unique challenges, including reimbursement approvals and price negotiations by group purchasing organizations and governments. Continuous R&D investments are crucial for innovation and market success. Despite these challenges, the industry benefits from an aging global population and increased healthcare spending in emerging markets. The report highlights the potential for new competitors, investors, and venture capitalists in the HbA1c testing market.

Advancements in surface chemistry, nanotechnology, and analytical sciences are expected to yield more convenient, accurate, and non-invasive HbA1c assays. The integration of deep machine learning algorithms and mobile apps for diabetes management promises to reduce hospitalizations and improve patient outcomes, heralding a new era of healthcare innovation.

Table of Contents

Chapter 1: Executive Summary

  • Introduction
  • Scope and Methodology
  • Market Summary
    • Table 1-1: Global HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Figure 1-1: Global HbA1c Testing Market, 2024-2029 ($ million)
  • Market Segmentation
  • Issues and Trends Affecting the HbA1c Testing Market
  • Competitive Analysis

Chapter 2: Introduction

  • Overview
    • Diagnosis
    • Type 1
    • Type 2
    • Classification
    • Type 1
    • Type 2
    • Gestational
    • Other
    • Risk Factors
    • Demographics of Diabetes
    • International Statistics
    • US Prevalence
    • US Incidence
    • US Deaths
    • US Cost
  • HbA1c

Chapter 3: HbA1c Testing by Setting

  • Introduction
    • Laboratory-based HbA1c Testing
    • POC HbA1c Testing
  • Market by HbA1c Testing Setting
    • Table 3-1: Global l HbA1c Test Sales Market and Distribution by Setting, 2024-2029 ($ million) estimated [HbA1c Lab and HbA1c POC]
    • Table 3-2: Selected POC Professional HbA1c Products
    • Table 3-3: Selected POC Self-Testing HbA1c Products

Chapter 4: HbA1c Testing Market by Technology Platforms

  • Overview
    • Chromatography
    • High-Performance Liquid Chromatography (HPLC)
    • Boronate Affinity
    • Immunoassay
    • Enzymatic and Micro-optical Methods
    • Others
  • Market by Technology
    • Table 4-1: Global HbA1c Test Sales Market and Distribution by Technology Platform, 2024-2029 ($ million) estimated [Enzymatic/MODM, HPLC, Immunoassay, Others]
    • Figure 4-1: Global HbA1c Test Sales Market by Technology Platform, 2024-2029 ($ million) estimated (Enzymatic/MODM, HPLC, Immunoassay, Others)
    • Figure 4-2: Global HbA1c Test Distribution by Technology Platform, 2024 (%) (Enzymatic/MODM, HPLC, Immunoassay, Others)

Chapter 5: HbA1c Testing Market Summary and Competitive

  • Total Global HbA1c Market
    • Table 5-1: Global HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Figure 5-1: Global HbA1c Testing Market Analysis, 2024-2029 ($ million)
  • Market Analysis by Country
    • Table 5-2: Global HbA1c Testing Market by Region, Revenues and % Market, 2024-2029 ($ million) estimated [Asia Pacific, Europe, Latin America, North America, ROW]
    • Figure 5-2: Global HbA1c Testing Market by Region, 2024-2029 ($ million) estimated (Asia Pacific, Europe, Latin America, North America, ROW)
    • Figure 5-3: Global HbA1c Testing Market Share, by Region, 2024 (%) (Asia Pacific, Europe, Latin America, North America, ROW)
  • North America
    • Table 5-3: North America HbA1c Testing Market Analysis, 2024-2029 ($ million)
  • Europe
    • Table 5-4: Europe HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Germany
    • France
    • Italy
    • United Kingdom
    • Spain
      • Figure 5-4: Europe HbA1c Testing Percentage Participation, by Country, 2024 (%) (France, German, Italy, Spain, United Kingdom, Rest of Europe)
  • Asia Pacific
    • Table 5-5: Asia Pacific HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Japan
    • China
    • India
      • Figure 5-5: Asia Pacific HbA1c Testing Percentage Participation, by Country 2024 (%) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America
    • Table 5-6: Latin America HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Figure 5-6: Latin America HbA1c Testing Percentage Participation, by Country, 2024 (%) (Brazil, Chile, Columbia, Mexico, Rest of Latin America)
  • Rest of World
    • Table 5-7: Rest of World HbA1c Testing Market Analysis, 2024-2029 ($ million)
  • Competitive Analysis
    • Table 5-8: Global HbA1c Testing Market Estimated Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Bio-Rad, Danaher (HemoCue and Beckman Coulter), Roche, Siemens Healthineers, Others]
    • Figure 5-7: Global HbA1c Testing Market Estimated Revenues, Leading Suppliers, 2024 ($ million) [Abbott, Bio-Rad, Danaher (HemoCue and Beckman Coulter), Roche, Siemens Healthineers, Others]
    • Figure 5-8: Global HbA1c Testing Market Share of Leading Suppliers, 2024 (%) [Abbott, Bio-Rad, Danaher (HemoCue and Beckman Coulter), Roche, Siemens Healthineers, Others]

Chapter 6: Issues and Trends in the HbA1c Testing Market

  • WHO Essential IVD List
    • Table 6-1: WHO Model List of Essential In Vitro Diagnostics (EDL)
  • Glycated Albumin Test
  • Reporting Changes
  • The Challenge of PAMA
  • Racial Differences in A1c
  • Telemedicine
  • LDT Update
  • Medicare and HbA1c Testing
  • IT and AI
  • Diabetes and the Aging World
  • Impact of Aging Populations
    • Figure 6-1: Global Population Trends, Total Population vs. Age 65+ Population, 2000-2050
  • Healthcare Efficiency
  • Diabetes Complications
  • Regulatory Issues
    • Table 6-2: Routine Chemistry CLIA Regulations Acceptable Limits (AP) Changes 2025
  • Dental Office HbA1c Testing

Chapter 7: HbA1c Testing Market Company Profiles

  • Introduction
  • Abbott
    • Table 7-1: Abbott Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 7-2: Abbott Revenues, 2020-2024 ($ million)
  • A. Menarini Diagnostics, S.r.l.
    • Table 7-3: A. Menarini Diagnostics Corporate Summary
    • Company Overview
    • Products
  • ARKRAY, Inc
    • Table 7-4: ARKRAY Corporate Summary
    • Company Overview
    • Products
  • Beckman Coulter/Danaher
    • Table 7-5: Beckman Coulter Corporate Summary
    • Company Overview
    • Products
  • Bio-Rad
    • Table 7-6: Bio-Rad Corporate Summary
    • Company Overview
    • Products
    • Financial Performance
      • Table 7-7: Bio-Rad Corporation Revenue, 2020-2024 ($ million)
  • DiaSys Diagnostics Systems GmbH
    • Table 7-8: DiaSys Diagnostics Systems Corporate Summary
    • Company Overview
    • Products
  • Diazyme Laboratories, Inc.
    • Table 7-9: Diazyme Laboratories Corporate Summary
    • Company Overview
    • Products
  • EKF Diagnostics Holdings Plc
    • Table 7-10: EKF Diagnostics Corporate Summary
    • Company Overview
    • Products
  • HemoCue/Danaher
    • Table 7-11: HemoCue Corporate Summary
    • Company Overview
    • Products
  • HUMAN Diagnostics.
    • Table 7-12: HUMAN Diagnostics Corporate Summary
    • Company Overview
    • Products
  • OSANG Healthcare Co, Ltd
    • Table 7-13: OSANG Healthcare Corporate Summary
    • Company Overview
    • Products
  • PTS Diagnostics, Inc
    • Table 7-14: PTS Diagnostics Corporate Summary
    • Company Overview
    • Products
  • QuidelOrtho Corporation
    • Table 7-15: QuidelOrtho Corporate Summary
    • Company Overview
    • Products
  • Performance Review
    • Table 7-16: QuidelOrtho Revenues, 2020-2024 ($ million)
  • Roche Diagnostics Corporation
    • Table 7-17: Roche Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Performance Review
    • Table 7-18: Roche Diagnostics, 2020-2024 (CHF millions)
  • Sebia
    • Table 7-19: Sebia Corporate Summary
    • Company Overview
    • Products
  • Sekisui Diagnostics, LLC
    • Table 7-20: Sekisui Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Siemens Healthineers GmbH
    • Table 7-21: Siemens Healthineers Corporate Summary
    • Company Overview
    • Products
  • Performance Review
    • Table 7-22: Siemens Healthineers, 2020-2024 (Euro-million)
  • Tosoh Bioscience, LLC
    • Table 7-23: Tosoh Bioscience Corporate Summary
    • Company Overview
    • Products
  • Trinity Biotech
    • Table 7-24: Trinity Biotech Corporate Summary
    • Company Overview
    • Products